US2022381788A1PendingUtilityA1

Methods of enhancing ms detection of tagged glycans

Assignee: WATERS TECHNOLOGIES CORPPriority: Jun 21, 2016Filed: May 2, 2022Published: Dec 1, 2022
Est. expiryJun 21, 2036(~9.9 yrs left)· nominal 20-yr term from priority
G01N 33/6848G01N 2400/10G01N 2560/00G01N 2400/00G01N 33/582G01N 33/50
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for derivatization of biomolecules including glycans or other biopolymers with one or more fluorescent, MS active compounds by reductive amination or rapid tagging in order to produce derivatized glycan having a pKa >7 and between about 200 Å and about 1000 Å of nonpolar surface area are described.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of tagging a glycan for enhanced mass spectroscopy and fluorescence signals comprising the step of reacting the glycan with an amphipathic compound having a non-polar surface area of greater than about 200 Å 2  and acidic residue with a pKa less than about 7 wherein a conjugate of the amphipathic compound and the glycan is formed. 
     
     
         2 . The method according to  claim 1  wherein the non-polar surface area is between about 200 A 2  and about 1000 A 2 . 
     
     
         3 . The method according to  claim 1  wherein the non-polar surface area is between about 200 A 2  and about 600 A 2 . 
     
     
         4 . The method according to  claim 1  wherein the non-polar surface area is between about 200 A 2  and about 500 A 2 . 
     
     
         5 . The method according to  claim 1 , wherein the amphipathic compound is a compound of Formula II: 
       
         
           
           
               
               
           
         
         wherein 
         each of R 1  and R 2  is independently selected from hydrogen, halogen, lower alkyl, lower alkenyl, lower alkynyl, lower alkanoyl, lower haloalkyl, lower haloalkenyl, lower haloalkynyl, lower cycloalkyl, lower acyloxy, hydroxy, amino, lower alkylamino, amido, nitro, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, sulfonate, sulfonic acid, N 3 , SH, SCH 3 , C(O)CH 3 , CO 2 CH 3  and CO 2 H; 
         R 3  is 
       
       
         
           
           
               
               
           
         
         R 3a  is selected from ester, amide, amine, oxygen, urea, carbamate, carbonate, sulfur, thiourea, thiocarbamate, alkyl or carbonyl; 
         R 3b  is 
       
       
         
           
           
               
               
           
         
         y=0 — 12; 
         z=1 — 12; 
         and salts or solvates thereof. 
       
     
     
         6 . The method according to  claim 5  wherein the glycan is selected from A2, FA2, M5, FA1G1, A2G1, FA2G1, FA2G2, FA2G1Ga1, FA2G2Ga1, FA2G2Sg1, FA2G1Ga2, FA2G2GaSg1, mannobiose (Man2), mannotriose (Man3), mannotetraose (Man4), mannopentaose (Man5), mannohexaose (Man6) and mannoheptaose (Man7). 
     
     
         7 . The method according to  claim 6 , wherein the glycan is an O-linked glycan. 
     
     
         8 . The method according to  claim 1 , wherein the amphipathic compound is a compound of Formula XI: 
       
         
           
           
               
               
           
         
         wherein 
         X=C or N 
         R 1  is O═C═N— or 
       
       
         
           
           
               
               
           
         
         R 2  is independently selected from —H, —C 1 -C 8  alkyl, —C 1 -C 8  cycloalkyl, halo, dialkylamino, CH 2 -dialkylamino, aminocarbonyl, alkoxycarbonyl, or alkoxy, but not Cl or O═C═N—; and 
         R 3  and R 4  are independently selected from —H, alkyl, alkylsulfonic acid, alkyl phosphonic acid, wherein either R 3  or R 4  is alkyl phosphonic acid, or alkylsulfonic acid. 
       
     
     
         9 . The method according to  claim 8 , wherein the glycan is selected from A2, FA2, M5, FA1G1, A2G1, FA2G1, FA2G2, FA2G1Ga1, FA2G2Ga1, FA2G2Sg1, FA2G1Ga2, FA2G2GaSg1, mannobiose (Man2), mannotriose (Man3), mannotetraose (Man4), mannopentaose (Man5), mannohexaose (Man6) and mannoheptaose (Man7). 
     
     
         10 . The method according to  claim 9 , wherein the glycan is a N-linked glycan. 
     
     
         11 . The method of  claim 1 , comprising forming the glycan by enzymatically digesting a glycoprotein. 
     
     
         12 . The method of  claim 1 , wherein the conjugate is formed by reductive amination. 
     
     
         13 . The method of  claim 12 , wherein the glycan is an O-linked glycan. 
     
     
         14 . The method of  claim 11 , wherein the conjugate is subjected to electron transfer dissociation (ETD) mass spectrometry.

Join the waitlist — get patent alerts

Track US2022381788A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.